Last update 21 Mar 2026

EB-DART-NK02

Overview

Basic Info

Drug Type
CAR-NK
Synonyms
DLL3/GD2 Dual-Target CAR-NK(Beijing Biotech), EB-DART-NK02
Target
DLL3 x GD2
Action
modulators
Mechanism
DLL3 modulators(Delta-like protein 3 modulators), GD2 modulators(Disialoganglioside GD2 modulators)
Therapeutic Areas-
Active Indication-
Inactive Indication-
Originator Organization
Beijing Biotech
Active Organization
Beijing Biotech
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with EB-DART-NK02
NCT07480213
/ RecruitingPhase 1/2
A Phase 1/2 Adaptive Dose-Escalation and Expansion Study of Dual-Targeting Chimeric Antigen Receptor Natural Killer (CAR-NK) Cells Directed Against DLL3, CD56 (NCAM1), and/or GD2 in Adults With Relapsed/Refractory Small Cell Lung Cancer
100 Clinical Results associated with EB-DART-NK02
Login to view more data
100 Translational Medicine associated with EB-DART-NK02
Login to view more data
100 Patents (Medical) associated with EB-DART-NK02
Login to view more data
100 Deals associated with EB-DART-NK02
Login to view more data

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free